Drugs / AJU-C711
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06931327 | Mar → Apr 2025 | hyperlipidemia | AJU Pharm Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AJU-C711 | “AJU-C711” NCT06931327 ↗ |